Monoclonal antibody
Showing all 11 results
-
Investigation Report on China’s Infliximab Market 2022-2031
$3200 – $4800 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Pertuzumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Daratumumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Omalizumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Golimumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Tocilizumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Infliximab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Ustekinumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Rituximab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Nivolumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page -
Investigation Report on China’s Trastuzumab Market 2021-2025
$2600 – $3900 Select options This product has multiple variants. The options may be chosen on the product page